Airija - anglų - HPRA (Health Products Regulatory Authority)

wpr healthcare limited - diazepam - tablets - 10 milligram

Airija - anglų - HPRA (Health Products Regulatory Authority)

wpr healthcare limited - diazepam - tablets - 5 milligram

Airija - anglų - HPRA (Health Products Regulatory Authority)

wpr healthcare limited - clarithromycin - film coated tablet - 500 milligram - macrolides

Airija - anglų - HPRA (Health Products Regulatory Authority)

wpr healthcare limited - clarithromycin - film coated tablet - 250 milligram - macrolides

Airija - anglų - HPRA (Health Products Regulatory Authority)

wpr healthcare limited - nitrazepam - tablets - 5 milligram

Airija - anglų - HPRA (Health Products Regulatory Authority)

wpr healthcare limited - nifedipine - capsule - 5 milligram

Airija - anglų - HPRA (Health Products Regulatory Authority)

wpr healthcare limited - nifedipine - capsule - 10 milligram

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

international brand management, llc - methyl salicylate (unii: lav5u5022y) (salicylic acid - unii:o414pz4lpz), menthol (unii: l7t10eip3a) (menthol - unii:l7t10eip3a) - ldo plus™ is a medicated hydrogel wound dressing in a metered dose (mdose™) bottle containing lidocaine 4%, an amide type local anesthetic, indicated for: painful wounds such as post-surgical incisions, cuts and abrasions. dosage apply to the affected area as directed. maximum 12 pumps per day. traumatized mucosa, secondary bacterial infection of the area of proposed application and known hypersensitivity to any of the components. lidocaine hydrochloride usp is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type. use in pregnancy: teratogenic effects - pregnancy category b. nursing mothers: it is not known whether this drug is excreted in human milk. because many drugs are excreted in human milk, caution should be exercised when lidocaine hydrochloride usp is administered to a nursing woman. pediatric use: dosage in children should be reduced, commensurate with age, body weight and physical condition. geriatric use: no overall clinical differences

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

international brand management, llc - methyl salicylate (unii: lav5u5022y) (salicylic acid - unii:o414pz4lpz), menthol (unii: l7t10eip3a) (menthol - unii:l7t10eip3a) - ldo plus™ is a medicated hydrogel wound dressing in a metered dose (mdose™) bottle containing lidocaine 4%, an amide type local anesthetic, indicated for: painful wounds such as post-surgical incisions, cuts and abrasions. dosage apply to the affected area as directed. maximum 12 pumps per day. traumatized mucosa, secondary bacterial infection of the area of proposed application and known hypersensitivity to any of the components. lidocaine hydrochloride usp is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type. use in pregnancy: teratogenic effects - pregnancy category b. nursing mothers: it is not known whether this drug is excreted in human milk. because many drugs are excreted in human milk, caution should be exercised when lidocaine hydrochloride usp is administered to a nursing woman. pediatric use: dosage in children should be reduced, commensurate with age, body weight and physical condition.

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

international brand management, llc - methyl salicylate (unii: lav5u5022y) (salicylic acid - unii:o414pz4lpz), menthol (unii: l7t10eip3a) (menthol - unii:l7t10eip3a) - ldo plus™ is a medicated hydrogel wound dressing in a metered dose (mdose™) bottle containing lidocaine 4%, an amide type local anesthetic, indicated for: painful wounds such as post-surgical incisions, cuts and abrasions. dosage apply to the affected area as directed. maximum 12 pumps per day. traumatized mucosa, secondary bacterial infection of the area of proposed application and known hypersensitivity to any of the components. lidocaine hydrochloride usp is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type. use in pregnancy: teratogenic effects - pregnancy category b. nursing mothers: it is not known whether this drug is excreted in human milk. because many drugs are excreted in human milk, caution should be exercised when lidocaine hydrochloride usp is administered to a nursing woman. pediatric use: dosage in children should be reduced, commensurate with age, body weight and physical condition. geriatric use: no overall clinical differences